1. Home
  2. GENI vs AMPH Comparison

GENI vs AMPH Comparison

Compare GENI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genius Sports Limited

GENI

Genius Sports Limited

HOLD

Current Price

$5.20

Market Cap

1.4B

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$19.44

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GENI
AMPH
Founded
2016
1996
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
GENI
AMPH
Price
$5.20
$19.44
Analyst Decision
Strong Buy
Buy
Analyst Count
16
7
Target Price
$13.19
$30.29
AVG Volume (30 Days)
5.9M
585.1K
Earning Date
01-01-0001
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.03
Revenue
N/A
$719,887,000.00
Revenue This Year
$29.73
$7.34
Revenue Next Year
$28.38
$4.81
P/E Ratio
N/A
$8.96
Revenue Growth
N/A
N/A
52 Week Low
$4.96
$17.03
52 Week High
$13.73
$31.26

Technical Indicators

Market Signals
Indicator
GENI
AMPH
Relative Strength Index (RSI) 31.42 33.23
Support Level N/A N/A
Resistance Level $6.75 $28.56
Average True Range (ATR) 0.43 1.22
MACD 0.05 -0.34
Stochastic Oscillator 12.86 20.91

Price Performance

Historical Comparison
GENI
AMPH

About GENI Genius Sports Limited

Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: